Vitamin Shoppe, Inc (VSI) Stock Price Up -5.7%
Vitamin Shoppe, Inc (NYSE:VSI) shares rose 5.7% during mid-day trading on Friday . The company traded as high as $5.95 and last traded at $5.38. Approximately 234,722 shares changed hands during mid-day trading, a decline of 64% from the average daily volume of 644,627 shares. The stock had previously closed at $5.70.
A number of analysts have issued reports on VSI shares. Morgan Stanley raised Vitamin Shoppe from an “underweight” rating to an “equal weight” rating and set a $14.00 price target for the company in a report on Thursday, May 11th. Gabelli downgraded Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Thursday, May 11th. Zacks Investment Research downgraded Vitamin Shoppe from a “hold” rating to a “strong sell” rating in a report on Saturday, May 13th. Barclays PLC reissued an “equal weight” rating and issued a $13.00 target price (down from $24.00) on shares of Vitamin Shoppe in a report on Sunday, May 14th. Finally, ValuEngine cut Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Four equities research analysts have rated the stock with a sell rating and seven have assigned a hold rating to the company’s stock. Vitamin Shoppe currently has a consensus rating of “Hold” and a consensus target price of $14.38.
The company’s market capitalization is $125.40 million. The stock’s 50 day moving average is $7.60 and its 200 day moving average is $13.77.
Vitamin Shoppe (NYSE:VSI) last announced its earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 EPS for the quarter, missing the consensus estimate of $0.39 by $0.16. The firm had revenue of $304.84 million during the quarter, compared to the consensus estimate of $314.74 million. Vitamin Shoppe had a positive return on equity of 8.33% and a negative net margin of 11.98%. The business’s revenue was down 8.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.55 EPS. Analysts anticipate that Vitamin Shoppe, Inc will post $0.79 earnings per share for the current year.
In other Vitamin Shoppe news, Director John D. Bowlin bought 40,000 shares of the stock in a transaction that occurred on Friday, August 25th. The shares were acquired at an average price of $5.50 per share, with a total value of $220,000.00. Following the completion of the purchase, the director now directly owns 56,028 shares in the company, valued at approximately $308,154. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.07% of the company’s stock.
A number of hedge funds and other institutional investors have recently bought and sold shares of VSI. BNP Paribas Arbitrage SA boosted its position in Vitamin Shoppe by 2.1% in the second quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock valued at $108,000 after buying an additional 192 shares in the last quarter. Municipal Employees Retirement System of Michigan lifted its position in shares of Vitamin Shoppe by 18.1% during the second quarter. Municipal Employees Retirement System of Michigan now owns 9,410 shares of the specialty retailer’s stock worth $110,000 after purchasing an additional 1,440 shares in the last quarter. Mason Street Advisors LLC lifted its position in shares of Vitamin Shoppe by 7.0% during the first quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock worth $112,000 after purchasing an additional 366 shares in the last quarter. Wolverine Trading LLC acquired a new position in shares of Vitamin Shoppe during the second quarter worth approximately $131,000. Finally, UBS Asset Management Americas Inc. lifted its position in shares of Vitamin Shoppe by 17,041.4% during the second quarter. UBS Asset Management Americas Inc. now owns 11,999 shares of the specialty retailer’s stock worth $140,000 after purchasing an additional 11,929 shares in the last quarter. 96.86% of the stock is currently owned by institutional investors and hedge funds.
About Vitamin Shoppe
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.